Amgen’s Acqusition of Onyx Leads Biopharmaceutical Dealmaking in 2013

Mergers and acquisition activity on both a volume and value basis is up thus far in 2013 comparative to 2012.
Sep 04, 2013
Volume 9, Issue 9